457 related articles for article (PubMed ID: 16465516)
1. [Health economics and HTA].
Kulp W; Greiner W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):257-63. PubMed ID: 16465516
[TBL] [Abstract][Full Text] [Related]
2. [HTA in the decision-making processes of health care institutions. Current state and relevant questions of regulatory health law].
Francke R; Hart D
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):241-50. PubMed ID: 16482461
[TBL] [Abstract][Full Text] [Related]
3. [The role of HTA in German health care. Do we need impact objectives?].
Gerhardus A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):233-40. PubMed ID: 16453136
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiological studies in the HTA evaluation process].
Behrens T; Ahrens W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):264-71. PubMed ID: 16477457
[TBL] [Abstract][Full Text] [Related]
5. [The critical role of research evidence in the framework of health technology assessment].
Sauerland S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):251-6. PubMed ID: 16477456
[TBL] [Abstract][Full Text] [Related]
6. Health technology assessment of medical devices: What is different? An overview of three European projects.
Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based decision-making 3: Health technology assessment.
O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
[TBL] [Abstract][Full Text] [Related]
8. Toward a sustainable European Network for Health Technology Assessment. The EUnetHTA project.
Kristensen FB; Chamova J; Hansen NW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):283-5. PubMed ID: 16453137
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?
Tarride JE; McCarron CE; Lim M; Bowen JM; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
Int J Technol Assess Health Care; 2008; 24(4):437-44. PubMed ID: 18828938
[TBL] [Abstract][Full Text] [Related]
10. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
[TBL] [Abstract][Full Text] [Related]
11. [The German Network for Evidence-based Medicine -- DNEbM].
Perleth M; Lühmann D; Antes G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):278-82. PubMed ID: 16465517
[TBL] [Abstract][Full Text] [Related]
12. [Health technology assessment (HTA). Developments in healthcare and potential for radiology].
Gizewski ER; Forsting M; Krombach GA; Schöffski O
Radiologe; 2014 Jun; 54(6):589-98. PubMed ID: 24844855
[TBL] [Abstract][Full Text] [Related]
13. Methods for determining cost-benefit ratios for pharmaceuticals in Germany.
von der Schulenburg J; Vauth C; Mittendorf T; Greiner W
Eur J Health Econ; 2007 Sep; 8 Suppl 1():S5-31. PubMed ID: 17582539
[TBL] [Abstract][Full Text] [Related]
14. [Innovation in health care: the role of HTA in the introduction of new technologies].
Bührlen B
Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):703-8. PubMed ID: 21147431
[TBL] [Abstract][Full Text] [Related]
15. Methods of international health technology assessment agencies for economic evaluations--a comparative analysis.
Mathes T; Jacobs E; Morfeld JC; Pieper D
BMC Health Serv Res; 2013 Sep; 13():371. PubMed ID: 24079858
[TBL] [Abstract][Full Text] [Related]
16. The Role of decision-analytic modelling in German health technology assessments.
Kuhlmann A; Treskova M; Braun S; Graf von der Schulenburg JM
Health Econ Rev; 2015; 5():7. PubMed ID: 25853005
[TBL] [Abstract][Full Text] [Related]
17. Resource modelling: the missing piece of the HTA jigsaw?
Thokala P; Dixon S; Jahn B
Pharmacoeconomics; 2015 Mar; 33(3):193-203. PubMed ID: 25411095
[TBL] [Abstract][Full Text] [Related]
18. [The role of randomised controlled trials in the medical evaluation of routine procedures].
Lange S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):272-7. PubMed ID: 16465518
[TBL] [Abstract][Full Text] [Related]
19. How to choose health technologies to be assessed by HTA? A review of criteria for priority setting.
Specchia ML; Favale M; Di Nardo F; Rotundo G; Favaretti C; Ricciardi W; de Waure C;
Epidemiol Prev; 2015; 39(4 Suppl 1):39-44. PubMed ID: 26499414
[TBL] [Abstract][Full Text] [Related]
20. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden.
Schwarzer R; Siebert U
Int J Technol Assess Health Care; 2009 Jul; 25(3):305-14. PubMed ID: 19619349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
